CV Sciences, Inc.
corporate_fare Company Profile
CV Sciences, Inc. (OTC:CVSI) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 12 items for CVSI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-09, rated 7/10. Across its 12 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for CVSI spans 4, 10-Q, 8-K, DEF 14A.
Recent high-impact activity:
- 10% Owner Charles Cheever Buys $114.8K of CVSI Stock at $0.02
- CV Sciences Q2 Revenue Drops 17.5%, Going Concern Warning Reiterated
- Shareholders Reject Reverse Stock Split Proposal Amidst Going Concern Warning
- Q1 Revenue Drops 11.4%, Net Loss Widens Amid Going Concern & Major Dilution
- CV Sciences Q1 Revenue Plunges 11% to $3.2M Amid Regulatory Headwinds
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for CVSI, detected from its recent SEC filings · based on capital-structure filings through 2026-03-26.
Going Concern Warning Issued · Critical Regulatory Changes for Hemp Products
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →